Patents by Inventor Sean Patrick Hollinshead

Sean Patrick Hollinshead has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 6-substituted-3-1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA receptor antagonists
    Patent number: 9469632
    Abstract: A TARP ?8 dependant AMPA receptor antagonist of the formula: wherein X is CH or N; A is and R1 is as defined herein; its pharmaceutically acceptable salts, uses, and methods for its preparation are described.
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: October 18, 2016
    Assignee: Eli Lilly and Company
    Inventors: Kevin Matthew Gardinier, Douglas Linn Gernert, Patric James Hahn, Sean Patrick Hollinshead, Albert Khilevich, Daniel Ray Mayhugh, Paul Leslie Ornstein, Warren Jaye Porter, Jon Kevin Reel, Jeffrey Michael Schkeryantz, Patrick Gianpietro Spinazze, Freddie Craig Stevens, Jeffrey Michael Witkin
  • 6-SUBSTITUTED-3H-1,3-BENZOTHIAZOL-2-ONE COMPOUNDS AS TARP-GAMMA 8 DEPENDENT AMPA RECEPTOR ANTAGONISTS
    Publication number: 20150344468
    Abstract: A TARP ?8 dependant AMPA receptor antagonist of the formula: wherein X is CH or N; A is and R1 is as defined herein; its pharmaceutically acceptable salts, uses, and methods for its preparation are described.
    Type: Application
    Filed: May 21, 2015
    Publication date: December 3, 2015
    Inventors: Kevin Matthew GARDINIER, Douglas Linn GERNERT, Patric James HAHN, Sean Patrick HOLLINSHEAD, Albert KHILEVICH, Daniel Ray MAYHUGH, Paul Leslie ORNSTEIN, Warren Jaye PORTER, Jon Kevin REEL, Jeffrey Michael SCHKERYANTZ, Patrick Gianpietro SPINAZZE, Freddie Craig STEVENS, Jeffrey Michael WITKIN
  • Purine compounds
    Patent number: 8759360
    Abstract: A compound of the formula: and pharmaceutical compositions for the treatment or prevention of pain.
    Type: Grant
    Filed: March 28, 2011
    Date of Patent: June 24, 2014
    Assignee: Eli Lilly and Company
    Inventors: Adam Jan Sanderson, Peter Charles Astles, Rossella Guidetti, Sean Patrick Hollinshead
  • Purine compounds used as CB2 agonists
    Patent number: 8710063
    Abstract: A compound of the formula: and pharmaceutical compositions for the treatment of pain.
    Type: Grant
    Filed: March 30, 2011
    Date of Patent: April 29, 2014
    Assignee: Eli Lilly and Company
    Inventor: Sean Patrick Hollinshead
  • PURINE COMPOUNDS USED AS CB2 AGONISTS
    Publication number: 20120329809
    Abstract: A compound of the formula (I) and pharmaceutical compositions for the treatment of pain.
    Type: Application
    Filed: March 30, 2011
    Publication date: December 27, 2012
    Applicant: ELI LILLY AND COMPANY
    Inventor: Sean Patrick Hollinshead
  • Purine compounds
    Patent number: 8252798
    Abstract: A compound of the formula: and pharmaceutical compositions for the treatment of pain.
    Type: Grant
    Filed: December 9, 2009
    Date of Patent: August 28, 2012
    Assignee: Eli Lilly and Company
    Inventors: Peter Charles Astles, Rossella Guidetti, Sean Patrick Hollinshead, Michael Wade Tidwell
  • Substituted piperazinyl pyrazines and pyridines as 5-HTreceptor antagonists
    Patent number: 8048884
    Abstract: The present invention provides selective 5-HT7 receptor antagonist compounds of Formula I and their use in the treatment of migraine: where A is —C(H)? or —N?; m is 0, 1 or 2; R1 is optionally substituted phenyl, optionally substituted pyrazol-4-yl; optionally substituted imidazolyl, optionally substituted pyridyl, or thienyl; R2 is hydrogen or methyl; and R3 and R4 are as defined herein.
    Type: Grant
    Filed: August 19, 2008
    Date of Patent: November 1, 2011
    Assignee: Eli Lilly and Company
    Inventors: Michael Philip Cohen, Sarah Lynne Hellman, Sean Patrick Hollinshead, Sandra Ann Filla, Michael Wade Tidwell
  • PURINE COMPOUNDS
    Publication number: 20110245255
    Abstract: A compound of the formula: and pharmaceutical compositions for the treatment or prevention of pain.
    Type: Application
    Filed: March 28, 2011
    Publication date: October 6, 2011
    Inventors: Adam Jan SANDERSON, Peter Charles ASTLES, Rossella GUIDETTI, Sean Patrick HOLLINSHEAD
  • Substituted carboxamides
    Patent number: 7960419
    Abstract: This application relates to a substituted carboxamide compound of formula I, or a pharmaceutically acceptable salt thereof, as defined herein, a pharmaceutical composition thereof, and its use in treating pain.
    Type: Grant
    Filed: June 7, 2007
    Date of Patent: June 14, 2011
    Assignee: Eli Lilly and Company
    Inventors: Ryan Thomas Backer, Matthew Joseph Fisher, Sean Patrick Hollinshead, Steven Lee Kuklish, Edward C R Smith, Kumiko Takeuchi
  • 3-indazolyl-4-pyridylisothiazoles
    Patent number: 7932274
    Abstract: The present invention provides 3-indazoyl-4-pyridylisothiazoles or a pharmaceutically acceptable salt thereof, pharmaceutical compositions thereof, and methods of using the same, as well as processes for preparing the same, and intermediates thereof.
    Type: Grant
    Filed: March 18, 2009
    Date of Patent: April 26, 2011
    Assignee: Eli Lilly and Company
    Inventors: Thomas Charles Britton, Veronique Dehlinger, Adam Michael Fivush, Sean Patrick Hollinshead, Benjamin Paul Vokits
  • Purine Compounds
    Publication number: 20100160288
    Abstract: A compound of the formula: and pharmaceutical compositions for the treatment of pain.
    Type: Application
    Filed: December 9, 2009
    Publication date: June 24, 2010
    Inventors: Peter Charles ASTLES, Rossella GUIDETTI, Michael Wade TIDWELL, Sean Patrick HOLLINSHEAD
  • SUBSTITUTED PIPERAZINYL PYRAZINES AND PYRIDINES AS 5-HT7 RECEPTOR ANTAGONISTS
    Publication number: 20100075976
    Abstract: The present invention provides selective 5-HT7 receptor antagonist compounds of Formula I and their use in the treatment of migraine: where A is —C(H)? or —N?; m is 0, 1 or 2; R1 is optionally substituted phenyl, optionally substituted pyrazol-4-yl; optionally substituted imidazolyl, optionally substituted pyridyl, or thienyl; R2 is hydrogen or methyl; and R3 and R4 are as defined herein.
    Type: Application
    Filed: August 19, 2008
    Publication date: March 25, 2010
    Inventors: Michael Philip Cohen, Sarah Lynne Hellman, Sean Patrick Hollinshead, Sandra Ann Filla, Michael Wade Tidwell
  • 3-INDAZOLYL-4-PYRIDYLISOTHIAZOLES
    Publication number: 20090253750
    Abstract: The present invention provides 3-indazoyl-4-pyridylisothiazoles or a pharmaceutically acceptable salt thereof, pharmaceutical compositions thereof, and methods of using the same, as well as processes for preparing the same, and intermediates thereof.
    Type: Application
    Filed: March 18, 2009
    Publication date: October 8, 2009
    Inventors: Thomas Charles Britton, Veronique Dehlinger, Adam Michael Fivush, Sean Patrick Hollinshead, Benjamin Paul Vokits
  • SUBSTITUTED CARBOXAMIDES
    Publication number: 20090182025
    Abstract: This application relates to a substituted carboxamide compound of formula I, or a pharmaceutically acceptable salt thereof, as defined herein, a pharmaceutical composition thereof, and its use in treating pain.
    Type: Application
    Filed: June 7, 2007
    Publication date: July 16, 2009
    Inventors: Ryan Thomas Backer, Matthew Joseph Fisher, Sean Patrick Hollinshead, Steven Lee Kuklish, Edward C.R. Smith, Kumiko Takeuchi
  • Pharmaceutical compounds
    Patent number: 6395735
    Abstract: The present invention provides novel indane-like compounds which can be useful for treating psychosis and other conditions associated with the modulation of a muscarinic receptor. The invention provides formulations and methods for using the novel compounds.
    Type: Grant
    Filed: December 19, 2000
    Date of Patent: May 28, 2002
    Assignee: Eli Lilly and Company
    Inventors: Sean Patrick Hollinshead, Philip Floyd Hughes, Jose Serafin Mendoza, Joseph Wendell Wilson, Bret Eugene Huff, Charles Howard Mitch, Michael Alexander Staszak, John Stanley Ward
  • Pharmaceutical compounds
    Publication number: 20010012848
    Abstract: The present invention provides novel indane-like compounds which can be useful for treating psychosis and other conditions associated with the modulation of a muscarinic receptor. The invention provides formulations and methods for using the novel compounds.
    Type: Application
    Filed: December 19, 2000
    Publication date: August 9, 2001
    Inventors: Sean Patrick Hollinshead, Philip Floyd Hughes, Jose Serafin Mendoza, Joseph Wendell Wilson, Bret Eugene Huff, Charles Howard Mitch, Michael Alexander Staszak, John Stanley Ward
  • Potassium channel inhibitors
    Patent number: 6083986
    Abstract: Compounds useful as potassium channel inhibitors and especially useful for the treatment of cardiac arrhythmias and cell proliferative disorders are described.
    Type: Grant
    Filed: July 15, 1997
    Date of Patent: July 4, 2000
    Assignees: ICAgen, Inc., Eli Lilly & Company
    Inventors: Neil Alexander Castle, Sean Patrick Hollinshead, Philip Floyd Hughes, Jose Serafin Mendoza, Joseph Wendell Wilson, George Salvatore Amato, Serge Beaudoin, Michael Gross, Grant McNaughton-Smith
  • Combinatorial process for preparing substituted thiophene libraries
    Patent number: 5942387
    Abstract: This invention relates to a novel solid phase process for the preparation of thiophene combinatorial libraries. These libraries have use for drug discovery and are used to form wellplate components of novel assay kits.
    Type: Grant
    Filed: August 25, 1997
    Date of Patent: August 24, 1999
    Assignee: Eli Lilly and Company
    Inventor: Sean Patrick Hollinshead